Skip to content
As Medicare open enrollment nears, seniors will face difficult choices despite CMS’ rosy assessment
Prescription drug coverage in Medicare will see sweeping changes – for both health plans and for the millions of American seniors they serve – […]
Federal Policy
Colorado price-setting board conflicts with federal law, BIO tells court
Colorado’s efforts to impose price controls on prescription drugs are preempted by federal law, according to a legal brief by the Biotechnology Innovation Organization
Colorado price-setting board conflicts with federal law, BIO tells court Read More »
As Medicare open enrollment nears, ‘M3P’ and the out-of-pocket cap loom large
Medicare beneficiaries will soon need to begin thinking about their coverage for 2025, with the open enrollment period opening on Oct. 15. The next
As Medicare open enrollment nears, ‘M3P’ and the out-of-pocket cap loom large Read More »
Sen. Cassidy calls on FDA to act, not abdicate, on drug device patents
Food and Drug Administration (FDA) inaction on patents for drug delivery devices has been troubling drug manufacturers for 20 years, and the situation is
Sen. Cassidy calls on FDA to act, not abdicate, on drug device patents Read More »
Senate Sustainable Aviation Caucus to back pro-SAF legislation
Sustainable aviation fuel (SAF) uses the power of biology to launch airliners. A group of senators said they will use their legislative power to
Senate Sustainable Aviation Caucus to back pro-SAF legislation Read More »
Exclusive: Sen. Todd Young on biosecurity, National Security Commission on Emerging Biotechnology (NSCEB)
Sen. Todd Young (R-IN) was recently named Chair of the National Security Commission on Emerging Biotechnology (NSCEB), established by Congress to recommend policy on biotech and national security.
Capitol Hill update: House advances PPRV reauthorization, Senate reviews IRA
During a busy week in Congress, House legislation to support drug development for pediatric rare diseases moved forward with bipartisan support, and a Senate
Capitol Hill update: House advances PPRV reauthorization, Senate reviews IRA Read More »
BIO’s view: Sanders’ latest attack on innovation misses realities about groundbreaking drugs
Yesterday, Sen. Bernie Sanders held a meeting about the new class of groundbreaking diabetes and weight-loss medicines. Next week, he will hold a hearing
Four key facts ahead of tomorrow’s drug pricing hearing
The Senate Finance Committee will hold a hearing tomorrow on “understanding the benefits of the Inflation Reduction Act.” Expect to hear a lot of rhetoric
Four key facts ahead of tomorrow’s drug pricing hearing Read More »
House members seek to block new wildlife refuge rules regarding GE crops
Members of Congress discussed legislation to block proposed federal rules that would regulate growth of genetically engineered crops on wildlife refuges during a Sept.
House members seek to block new wildlife refuge rules regarding GE crops Read More »